FI56188B - PROCEDURE FOR FRAMSTATING AV 2-BROMO-6BETA, 9ALFA-DIFLUOR-11BETA-HYDROXIPREGNA-1,4-DIEN-3,20-DIONDERIVAT MED ANTI-INFLAMMATORISK NETWORK - Google Patents
PROCEDURE FOR FRAMSTATING AV 2-BROMO-6BETA, 9ALFA-DIFLUOR-11BETA-HYDROXIPREGNA-1,4-DIEN-3,20-DIONDERIVAT MED ANTI-INFLAMMATORISK NETWORKInfo
- Publication number
- FI56188B FI56188B FI750537A FI750537A FI56188B FI 56188 B FI56188 B FI 56188B FI 750537 A FI750537 A FI 750537A FI 750537 A FI750537 A FI 750537A FI 56188 B FI56188 B FI 56188B
- Authority
- FI
- Finland
- Prior art keywords
- inflammatorisk
- hydroxipregna
- dionderivat
- 9alfa
- framstating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
- C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0092—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by an OH group free esterified or etherified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/0026—Oxygen-containing hetero ring cyclic ketals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/0026—Oxygen-containing hetero ring cyclic ketals
- C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Pain & Pain Management (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8928/74A GB1499822A (en) | 1974-02-27 | 1974-02-27 | 2-bromo-6beta-fluoropregna-1,4-diene-3,20-diones |
GB2998474 | 1974-07-05 | ||
GB3294574 | 1974-07-25 | ||
GB4998274 | 1974-11-19 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI750537A FI750537A (en) | 1975-08-28 |
FI56188B true FI56188B (en) | 1979-08-31 |
FI56188C FI56188C (en) | 1979-12-10 |
Family
ID=27447687
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI750537A FI56188C (en) | 1974-02-27 | 1975-02-25 | FREQUENCY REFRIGERATION FOR 2-BROMO-6BETA 9ALFA-DIFLUOR-11BETA-HYDROXIPREGNA-1,4-DIENE-3,20-DIONDERIVAT WITH ANTI-FLAMMING NETWORK |
Country Status (18)
Country | Link |
---|---|
JP (1) | JPS5614677B2 (en) |
AR (1) | AR218601A1 (en) |
BE (1) | BE826030A (en) |
CA (1) | CA1064476A (en) |
CH (1) | CH608243A5 (en) |
DE (3) | DE2508136C3 (en) |
DK (1) | DK144068C (en) |
ES (3) | ES435067A1 (en) |
FI (1) | FI56188C (en) |
FR (1) | FR2261776B1 (en) |
GB (1) | GB1499822A (en) |
IE (1) | IE42112B1 (en) |
LU (1) | LU71908A1 (en) |
NO (1) | NO144527C (en) |
NZ (1) | NZ176716A (en) |
RO (1) | RO78881A (en) |
SE (1) | SE410736B (en) |
YU (3) | YU108381A (en) |
-
1974
- 1974-02-27 GB GB8928/74A patent/GB1499822A/en not_active Expired
-
1975
- 1975-02-10 CA CA219,681A patent/CA1064476A/en not_active Expired
- 1975-02-14 FR FR7504616A patent/FR2261776B1/fr not_active Expired
- 1975-02-19 DK DK61575A patent/DK144068C/en not_active IP Right Cessation
- 1975-02-20 NZ NZ176716A patent/NZ176716A/en unknown
- 1975-02-24 IE IE379/75A patent/IE42112B1/en unknown
- 1975-02-24 AR AR257732A patent/AR218601A1/en active
- 1975-02-25 DE DE2508136A patent/DE2508136C3/en not_active Expired
- 1975-02-25 ES ES435067A patent/ES435067A1/en not_active Expired
- 1975-02-25 CH CH232575A patent/CH608243A5/en not_active IP Right Cessation
- 1975-02-25 FI FI750537A patent/FI56188C/en not_active IP Right Cessation
- 1975-02-25 NO NO750633A patent/NO144527C/en unknown
- 1975-02-25 LU LU71908A patent/LU71908A1/xx unknown
- 1975-02-26 SE SE7502146A patent/SE410736B/en unknown
- 1975-02-26 RO RO7581496A patent/RO78881A/en unknown
- 1975-02-26 BE BE153787A patent/BE826030A/en not_active IP Right Cessation
- 1975-02-26 JP JP2298075A patent/JPS5614677B2/ja not_active Expired
- 1975-07-25 DE DE2533377A patent/DE2533377C3/en not_active Expired
- 1975-07-25 DE DE2533323A patent/DE2533323C3/en not_active Expired
-
1977
- 1977-02-15 ES ES455933A patent/ES455933A1/en not_active Expired
- 1977-02-15 ES ES455934A patent/ES455934A1/en not_active Expired
-
1981
- 1981-04-27 YU YU01083/81A patent/YU108381A/en unknown
- 1981-04-27 YU YU01084/81A patent/YU108481A/en unknown
- 1981-04-27 YU YU01082/81A patent/YU108281A/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE429970B (en) | PROCEDURE FOR PREPARING GLUCOPYRANOSIDO-1,6-MANNIT | |
SE428562C (en) | PROCEDURE FOR PURINATE DERIVATIVES | |
SE423633B (en) | PROCEDURE FOR PREPARING 4-DEMETOXY-DAUNOMYCINE | |
SE421919B (en) | PROCEDURE FOR PREPARING 2-TETRAHYDROFURFURYL-6,7-BENZOMORPHANES | |
DK397575A (en) | PROCEDURE FOR THE PREPARATION OF 1,3,4-TRISUBSTITUTED 4-ARYLPIPERIDINES | |
SE7508406L (en) | PROCEDURE FOR PREPARING POLYPHENYLENOXIDE. | |
SE7503689L (en) | PROCEDURE FOR THE PREPARATION OF 1,1-DIARYL-1-OXADIAZOLE ALKYLAMINES | |
SE431211B (en) | PROCEDURE FOR PREPARING N-ACYLAMINO-ALFA-ARYLACETAMIDO-CEPHALOSPORINES | |
SE7508074L (en) | PROCEDURE FOR PREPARING STILBENDER DERIVATIVES. | |
SE421612B (en) | PROCEDURE FOR PREPARING ALFA-6-DEOXI-5-HYDROXYTETRACYCLINE | |
SE418292B (en) | PROCEDURE FOR PREPARING 5-ARYL-2-FURAMIDINES | |
DK356375A (en) | PROCEDURE FOR THE PREPARATION OF 2-THIOL-4,5-DIPHENYLOXAZOLE-S DERIVATIVES | |
SE400960B (en) | PROCEDURE FOR PREPARING ALHŸ3 (POŸ4) Ÿ2 3HŸ2O | |
SE422057B (en) | PROCEDURE FOR PREPARING CERTAIN OMEGA-SUBSTITUTED OMEGA-NOR-13,14-DEHYDRO-PROSTAGLANDINES | |
SE414926B (en) | PROCEDURE FOR PREPARING 1-ALKYL-2- (PHENOXIMETHYL) -5-NITROIMIDAZOLES | |
SE422210B (en) | ANALOGY PROCEDURE FOR PREPARING SUBSTITUTED INDOLS | |
DK506075A (en) | PROCEDURE FOR THE PREPARATION OF OSTRENE-3,17-DIONE DERIVATIVES | |
SE404364B (en) | PROCEDURE FOR PREPARING CERTAIN 5-SULPHONYLPHENYL-TETRAZOLE DERIVATIVES | |
NO139684C (en) | PROCEDURE FOR THE PREPARATION OF N, N-DIALLYLDICLOROCETAMIDE | |
SE421310B (en) | PROCEDURE FOR PREPARING SUBSTITUTED BENZOYLPYRIDINES | |
SE7512422L (en) | PROCEDURE FOR THE PREPARATION OF 1,2,3,4-TETRAHYDROISOCHINOLINES | |
FI56188B (en) | PROCEDURE FOR FRAMSTATING AV 2-BROMO-6BETA, 9ALFA-DIFLUOR-11BETA-HYDROXIPREGNA-1,4-DIEN-3,20-DIONDERIVAT MED ANTI-INFLAMMATORISK NETWORK | |
SE7507482L (en) | PROCEDURE FOR THE PREPARATION OF SUBSTITUTED L-SULPHONYLBENSIMIDAZOLES. | |
DK505275A (en) | PROCEDURE FOR PREPARING 7,7-DIPHENYLHEXAHYDRO-1,4-OXAZEPINES | |
SE431325B (en) | PROCEDURE FOR PREPARING 6-SUBSTITUTED 2,3-DIMETOXY-5-METHYL-1,4-BENZOQINONS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM | Patent lapsed |
Owner name: PIERREL S.P.A. |